NCT01494506 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 151
- group Id
- BG001
- value
- 149
- group Id
- BG002
- value
- 117
- group Id
- BG003
- value
- 417
- units
- Participants
- groups
- description
- MM-398 Q3W IV MM-398: Arm A: MM-398 120 mg/m2 IV Q3W Arm C: MM-398 80mg/m2 IV Q2W
- id
- BG000
- title
- MM-398
- description
- 5 Fluorouracil and Leucovorin IV 5 Fluorouracil: Arm B: 5 Fluorouracil 2000 mg/m2 IV for 4 weeks followed by 2 weeks of rest every 6 weeks Arm C: 5 Fluorouracil 2400 mg/m2 IV every 2 weeks Leucovorin: Arm B: Leucovorin 200 mg/m2 IV for 4 weeks followed by 2 weeks of rest every 6 weeks Arm C: Leucovorin 400 mg/m2 IV every 2 weeks
- id
- BG001
- title
- 5 Fluorouracil and Leucovorin IV
- description
- MM-398, 5-FU and Leucovorin Q2W IV MM-398: Arm A: MM-398 120 mg/m2 IV Q3W Arm C: MM-398 80mg/m2 IV Q2W 5 Fluorouracil: Arm B: 5 Fluorouracil 2000 mg/m2 IV for 4 weeks followed by 2 weeks of rest every 6 weeks Arm C: 5 Fluorouracil 2400 mg/m2 IV every 2 weeks Leucovorin: Arm B: Leucovorin 200 mg/m2 IV for 4 weeks followed by 2 weeks of rest every 6 weeks Arm C: Leucovorin 400 mg/m2 IV every 2 weeks
- id
- BG002
- title
- MM-398, 5-FU and Leucovorin
- description
- Total of all reporting groups
- id
- BG003
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- <=18 years
- measurements
- group Id
- BG000
- value
- 151
- group Id
- BG001
- value
- 149
- group Id
- BG002
- value
- 117
- group Id
- BG003
- value
- 417
- title
- Between 18 and 65 years
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- >=65 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Categorical
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 10.13
- value
- 63.6
- group Id
- BG001
- spread
- 9.65
- value
- 61.8
- group Id
- BG002
- spread
- 9.06
- value
- 63.2
- group Id
- BG003
- spread
- 9.68
- value
- 62.8
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 64
- group Id
- BG001
- value
- 68
- group Id
- BG002
- value
- 48
- group Id
- BG003
- value
- 180
- title
- Female
- measurements
- group Id
- BG000
- value
- 87
- group Id
- BG001
- value
- 81
- group Id
- BG002
- value
- 69
- group Id
- BG003
- value
- 237
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- title
- American Indian or Alaska Native
- categories
- measurements
- group Id
- BG000
- value
- 52
- group Id
- BG001
- value
- 50
- group Id
- BG002
- value
- 34
- group Id
- BG003
- value
- 136
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 10
- title
- Black or African American
- categories
- measurements
- group Id
- BG000
- value
- 89
- group Id
- BG001
- value
- 92
- group Id
- BG002
- value
- 72
- group Id
- BG003
- value
- 253
- title
- White
- categories
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 17
- title
- other race
- param Type
- NUMBER
- title
- RACE (NIH/OMB)
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 22
- group Id
- BG001
- value
- 22
- group Id
- BG002
- value
- 18
- group Id
- BG003
- value
- 62
- title
- 100% = normal, no complaints, no signs of disease
- categories
- measurements
- group Id
- BG000
- value
- 64
- group Id
- BG001
- value
- 54
- group Id
- BG002
- value
- 51
- group Id
- BG003
- value
- 169
- title
- 90% = normal activity, few symptoms of disease
- categories
- measurements
- group Id
- BG000
- value
- 50
- group Id
- BG001
- value
- 61
- group Id
- BG002
- value
- 38
- group Id
- BG003
- value
- 149
- title
- 80% = normal activity, some symptoms of disease
- categories
- measurements
- group Id
- BG000
- value
- 15
- group Id
- BG001
- value
- 11
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 33
- title
- 70% = caring for self, unable to work
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 2
- title
- 60% [2] = needs help, can manage most tasks
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 1
- title
- 50%[2]= needs help often and medical care
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- title
- Not recorded
- description
- 1. One patient in the 5-FU/LV arm did not have a recorded Baseline KPS value. 2. Designation of the KPS level for the randomization strata is made during the screening period prior to knowledge of the treatment assignment. Baseline KPS is the last observed KPS value prior to treatment in treated patients and the last observed value in patients who were randomized and did not receive study drug. The observed baseline KPS value may be recorded post-randomization.
- param Type
- NUMBER
- title
- Karnofsky Performance Status (Baseline KPS)[1]
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 92
- group Id
- BG001
- value
- 77
- group Id
- BG002
- value
- 70
- group Id
- BG003
- value
- 239
- title
- Head
- categories
- measurements
- group Id
- BG000
- value
- 16
- group Id
- BG001
- value
- 26
- group Id
- BG002
- value
- 12
- group Id
- BG003
- value
- 54
- title
- Body
- categories
- measurements
- group Id
- BG000
- value
- 24
- group Id
- BG001
- value
- 24
- group Id
- BG002
- value
- 14
- group Id
- BG003
- value
- 62
- title
- Tail
- categories
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 17
- title
- Multiple locations including head
- categories
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 9
- group Id
- BG003
- value
- 30
- title
- Multiple locations not including head
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 15
- title
- Unknown = not specified
- param Type
- NUMBER
- title
- Pancreatic Primary Tumor Location
- unit Of Measure
- participants
- population Description
- All randomized patients.
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 151
- group Id
- BG001
- value
- 149
- group Id
- BG002
- value
- 117
- group Id
- BG003
- value
- 417
- units
- Participants
- groups
- description
- MM-398 Q3W IV MM-398: Arm A: MM-398 120 mg/m2 IV Q3W Arm C: MM-398 80mg/m2 IV Q2W
- id
- BG000
- title
- MM-398
- description
- 5 Fluorouracil and Leucovorin IV 5 Fluorouracil: Arm B: 5 Fluorouracil 2000 mg/m2 IV for 4 weeks followed by 2 weeks of rest every 6 weeks Arm C: 5 Fluorouracil 2400 mg/m2 IV every 2 weeks Leucovorin: Arm B: Leucovorin 200 mg/m2 IV for 4 weeks followed by 2 weeks of rest every 6 weeks Arm C: Leucovorin 400 mg/m2 IV every 2 weeks
- id
- BG001
- title
- 5 Fluorouracil and Leucovorin IV
- description
- MM-398, 5-FU and Leucovorin Q2W IV MM-398: Arm A: MM-398 120 mg/m2 IV Q3W Arm C: MM-398 80mg/m2 IV Q2W 5 Fluorouracil: Arm B: 5 Fluorouracil 2000 mg/m2 IV for 4 weeks followed by 2 weeks of rest every 6 weeks Arm C: 5 Fluorouracil 2400 mg/m2 IV every 2 weeks Leucovorin: Arm B: Leucovorin 200 mg/m2 IV for 4 weeks followed by 2 weeks of rest every 6 weeks Arm C: Leucovorin 400 mg/m2 IV every 2 weeks
- id
- BG002
- title
- MM-398, 5-FU and Leucovorin
- description
- Total of all reporting groups
- id
- BG003
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- <=18 years
- measurements
- group Id
- BG000
- value
- 151
- group Id
- BG001
- value
- 149
- group Id
- BG002
- value
- 117
- group Id
- BG003
- value
- 417
- title
- Between 18 and 65 years
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 0
- title
- >=65 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Categorical
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 10.13
- value
- 63.6
- group Id
- BG001
- spread
- 9.65
- value
- 61.8
- group Id
- BG002
- spread
- 9.06
- value
- 63.2
- group Id
- BG003
- spread
- 9.68
- value
- 62.8
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 64
- group Id
- BG001
- value
- 68
- group Id
- BG002
- value
- 48
- group Id
- BG003
- value
- 180
- title
- Female
- measurements
- group Id
- BG000
- value
- 87
- group Id
- BG001
- value
- 81
- group Id
- BG002
- value
- 69
- group Id
- BG003
- value
- 237
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- title
- American Indian or Alaska Native
- categories
- measurements
- group Id
- BG000
- value
- 52
- group Id
- BG001
- value
- 50
- group Id
- BG002
- value
- 34
- group Id
- BG003
- value
- 136
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 4
- group Id
- BG003
- value
- 10
- title
- Black or African American
- categories
- measurements
- group Id
- BG000
- value
- 89
- group Id
- BG001
- value
- 92
- group Id
- BG002
- value
- 72
- group Id
- BG003
- value
- 253
- title
- White
- categories
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 17
- title
- other race
- param Type
- NUMBER
- title
- RACE (NIH/OMB)
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 22
- group Id
- BG001
- value
- 22
- group Id
- BG002
- value
- 18
- group Id
- BG003
- value
- 62
- title
- 100% = normal, no complaints, no signs of disease
- categories
- measurements
- group Id
- BG000
- value
- 64
- group Id
- BG001
- value
- 54
- group Id
- BG002
- value
- 51
- group Id
- BG003
- value
- 169
- title
- 90% = normal activity, few symptoms of disease
- categories
- measurements
- group Id
- BG000
- value
- 50
- group Id
- BG001
- value
- 61
- group Id
- BG002
- value
- 38
- group Id
- BG003
- value
- 149
- title
- 80% = normal activity, some symptoms of disease
- categories
- measurements
- group Id
- BG000
- value
- 15
- group Id
- BG001
- value
- 11
- group Id
- BG002
- value
- 7
- group Id
- BG003
- value
- 33
- title
- 70% = caring for self, unable to work
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 2
- group Id
- BG003
- value
- 2
- title
- 60% [2] = needs help, can manage most tasks
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- group Id
- BG003
- value
- 1
- title
- 50%[2]= needs help often and medical care
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 0
- group Id
- BG003
- value
- 1
- title
- Not recorded
- description
- 1. One patient in the 5-FU/LV arm did not have a recorded Baseline KPS value. 2. Designation of the KPS level for the randomization strata is made during the screening period prior to knowledge of the treatment assignment. Baseline KPS is the last observed KPS value prior to treatment in treated patients and the last observed value in patients who were randomized and did not receive study drug. The observed baseline KPS value may be recorded post-randomization.
- param Type
- NUMBER
- title
- Karnofsky Performance Status (Baseline KPS)[1]
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 92
- group Id
- BG001
- value
- 77
- group Id
- BG002
- value
- 70
- group Id
- BG003
- value
- 239
- title
- Head
- categories
- measurements
- group Id
- BG000
- value
- 16
- group Id
- BG001
- value
- 26
- group Id
- BG002
- value
- 12
- group Id
- BG003
- value
- 54
- title
- Body
- categories
- measurements
- group Id
- BG000
- value
- 24
- group Id
- BG001
- value
- 24
- group Id
- BG002
- value
- 14
- group Id
- BG003
- value
- 62
- title
- Tail
- categories
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 17
- title
- Multiple locations including head
- categories
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 9
- group Id
- BG003
- value
- 30
- title
- Multiple locations not including head
- categories
- measurements
- group Id
- BG000
- value
- 5
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 6
- group Id
- BG003
- value
- 15
- title
- Unknown = not specified
- param Type
- NUMBER
- title
- Pancreatic Primary Tumor Location
- unit Of Measure
- participants
- population Description
- All randomized patients.
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle